NeoIndicate

NeoIndicateNeoIndicateNeoIndicate

NeoIndicate

NeoIndicateNeoIndicateNeoIndicate
  • Home
  • Platform Technology
  • Publications
  • News
  • Our People
  • Brochure
  • More
    • Home
    • Platform Technology
    • Publications
    • News
    • Our People
    • Brochure
  • Home
  • Platform Technology
  • Publications
  • News
  • Our People
  • Brochure
data:image/gif;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=

About us

Advanced Tools for Improved Tumor Detection

Our agents specifically recognize unique biomarkers only present in the tumor microenvironment.

Targeted Imaging Agents

Each agent is easily modified for tumor diagnosis, fluorescent guided surgery, specific MRI and PET imaging or targeted tumor therapeutics.

Tumor Specific Treatment

Therapeutics are targeted for brain tumors, melanoma, breast, ovarian, prostate and lung cancer.

Video

Neo-001 Technology

Our team

Susann Brady-Kalnay, PhD

Susann Brady-Kalnay, PhD

Susann Brady-Kalnay, PhD

Chief Scientific Officer

Ted Gastineau

Susann Brady-Kalnay, PhD

Susann Brady-Kalnay, PhD

Chief Executive Officer

Samantha Oblander, PhD

Susann Brady-Kalnay, PhD

Samantha Oblander, PhD

Chief Operating Officer

Contact Us

For more information, drop us a line!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NeoIndicate

Wellington, Ohio 44090, United States

NeoIndicate@neoindicate.com

Hours

Open today

09:00 am – 05:00 pm


Copyright © 2023 NeoIndicate - All Rights Reserved.

Powered by GoDaddy Website Builder